Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in acelrx pharmaceuticals, inc. of class action lawsuit and upcoming deadline - acrx

New york, new york--(newsfile corp. - july 23, 2021) - pomerantz llp announces that a class action lawsuit has been filed against acelrx pharmaceuticals, inc. ("acelrx" or the "company") (nasdaq: acrx) and certain of its officers. the class action, filed in the united states district court for the northern district of california, and docketed under 21-cv-04353, is on behalf of a class consisting of all persons and entities other than defendants that purchased...
ACRX Ratings Summary
ACRX Quant Ranking